Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

OMCL PEER ANALYSIS

Omnicell Inc — metric-by-metric comparison with peers and the industry median

OMCLOmnicell Inc

🇺🇸 USA · NASDAQ · Healthcare · Health Information Services

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Health Information Services

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial Health
OMCLIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
OMCL+52.1%PME-32.2%FONET+126.7%
Year-to-Date (YTD)
OMCL-0.4%PME-3.7%FONET+82.8%
1-Year
Split-adjusted
OMCL+52.1%TDOC+6.6%SDGR-24.9%CERT-42.6%PRVA+26.4%SLGC—
Year-to-Date (YTD)
OMCL-0.4%TDOC+29.6%SDGR-10.0%CERT-25.8%PRVA+14.8%SLGC-2.7%

Key Metric Comparison

P/E

Lower is better
OMCL101.45PME94.60FONET19.63Median 41.62

ROE

Higher is better
OMCL1.6%PME76.8%FONET15.6%Median 2.7%

Net Margin

Higher is better
OMCL1.7%PME97.6%FONET26.0%Median 1.5%

Revenue Growth

Higher is better
OMCL7.9%PME30.3%FONET53.5%Median 7.1%

P/E

Lower is better
OMCL101.45TDOC—SDGR—CERT—PRVA163.64SLGC—Median 41.62

ROE

Higher is better
OMCL1.6%TDOC-12.4%SDGR-30.1%CERT-1.4%PRVA3.1%SLGC-23.7%Median 2.7%

Net Margin

Higher is better
OMCL1.7%TDOC-6.8%SDGR-40.6%CERT-3.6%PRVA1.0%SLGC-159.5%Median 1.5%

Revenue Growth

Higher is better
OMCL7.9%TDOC-1.5%SDGR10.6%CERT6.4%PRVA24.7%SLGC-19.7%Median 7.1%

All Metrics

Valuation
MetricOMCLPMEFONETInd. Median
P/E101.4594.6019.63●41.62
P/B1.65●57.082.542.45
EV/EBITDA15.91116.6110.08●15.96
P/S1.69●92.295.112.30
Financial Health
MetricOMCLPMEFONETInd. Median
Current Ratio1.466.22●2.311.83
Debt/Equity16.1%1.1%●2.5%22.0%
NetDebt/EBITDA-0.71-1.16●-0.21-0.01
Profitability
MetricOMCLPMEFONETInd. Median
Net Margin1.7%97.6%●26.0%1.5%
ROE1.6%76.8%●15.6%2.7%
ROA1.0%56.7%●13.2%1.4%
EBITDA Margin10.2%78.4%●49.6%12.4%
Growth + Dividend
MetricOMCLPMEFONETInd. Median
Rev. Growth7.9%30.3%53.5%●7.1%
NI Growth-3.5%138.8%●26.6%23.6%
Div. Yield—0.3%●0.0%0.7%
Payout—24.5%0.0%9.6%
Valuation
MetricOMCLTDOCSDGRCERTPRVASLGCInd. Median
P/E101.45●———163.64—41.62
P/B1.651.223.801.01●4.737.282.45
EV/EBITDA15.9133.36—11.68●55.88—15.96
P/S1.690.65●4.672.461.5944.222.30
Financial Health
MetricOMCLTDOCSDGRCERTPRVASLGCInd. Median
Current Ratio1.462.802.741.881.6117.79●1.83
Debt/Equity16.1%77.7%34.1%29.5%1.2%0.6%●22.0%
NetDebt/EBITDA-0.715.013.091.49-7.28●3.31-0.01
Profitability
MetricOMCLTDOCSDGRCERTPRVASLGCInd. Median
Net Margin1.7%●-6.8%-40.6%-3.6%1.0%-159.5%1.5%
ROE1.6%-12.4%-30.1%-1.4%3.1%●-23.7%2.7%
ROA1.0%-5.5%-15.0%-1.0%1.7%●-20.8%1.4%
EBITDA Margin10.2%2.3%-37.1%24.1%●2.5%-166.7%12.4%
Growth + Dividend
MetricOMCLTDOCSDGRCERTPRVASLGCInd. Median
Rev. Growth7.9%-1.5%10.6%6.4%24.7%●-19.7%7.1%
NI Growth-3.5%———39.3%●—23.6%
Div. Yield——————0.7%
Payout——————9.6%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on OMCL

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 8, 26. This content is for informational purposes only and is not investment advice.